Role of sympathetic blocking agents in outflow obstruction.
Caine
M
M
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011469:Prostatic Diseases / Q000188:drug therapy*; D014524:Urethral Obstruction / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine